Q1 2025 - Earnings Conference Call May 6, 2025 10:30 AM ETCompany ParticipantsMegan Repine – VP, IRBradley Childers - ...

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

Tesla 's sales slump. Motley Fool contributor Jason Hall joins host Ricky Mulvey for a look at Texas Instruments and Taiwan Semiconductor. To catch full episodes of all The Motley Fool's free podcasts ...

In this podcast, Motley Fool analyst Sanmeet Deo and host Mary Long discuss: Poor results from Tesla's automotive segment.

Tariffs have been a key feature of his first 100 days and at a so-called "Liberation Day" event at the White House, Trump ...

The people who grow and sell America's food no longer trust the USDA. We made a timeline to show you what happened.

EndoPeak is a daily supplement made for men who want to improve their sex life, naturally and without harsh chemicals or ...

How Mitolyn, developed by Andrew Lambert, utilizes the Purple Peel Exploit to target fat loss at the mitochondrial level. A ...

The California Newsroom and the Texas Standard team up to examine how the Trump administration is changing life in two of the ...

Add to that the $500 million the state’s insurer of last resort, the FAIR Plan, will get to pass along to every policyholder in California to help cover its losses in the Los Angeles fires, and ...

Korean cosmetics face U.S. pullbacks and price hikes over FDA regulations and rising tariffs, sparking panic buying. Though MoCRA doesn't cover SPF, fear of stricter rules led brands to halt or ...